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TRIM-NHL  proteins  are  key  regulators  of developmental  transitions,  for example  promoting  differentia-
tion,  while  inhibiting  cell growth  and proliferation,  in  stem  and  progenitor  cells.  Abnormalities  in these
proteins  have  been  also  associated  with  human  diseases,  particularly  affecting  muscular  and  neuronal
functions,  making  them  potential  targets  for therapeutic  intervention.  The  purpose  of this  review  is  to
provide  a systematic  and  comprehensive  summary  on the  most  studied  TRIM-NHL  proteins,  highlight-
ing  examples  where  connections  were  established  between  structural  features,  molecular  functions  andei-P26
RIM32
IN-41
RIM71
ardet-Biedl syndrome
imb girdle muscular dystrophy 2H
biological  outcomes.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).arcotubular myopathy
. The TRIM-NHL proteins: domains and associated
olecular functions
The TRIpartite Motif (TRIM) is constituted by three main
omains: a Really Interesting New Gene (RING) ﬁnger, one or,
ore commonly, two B-Box-type zinc ﬁngers (BB1 and BB2) and
 Coiled-Coil (CC) (Fig. 1A). The TRIM is always located towards the
-terminus of the protein and the order of, as well as the spacing
etween individual domains, is highly conserved [1]. TRIM-NHL
roteins (referred to as “C-VII” subfamily) represent one of the
ine subfamilies of TRIM proteins (from “C-I” to “C-IX”), whose
lassiﬁcation is based on the presence of an additional domain,
HL, which is positioned C-terminally from the TRIM [2]. The NHL
tands for NCL-1/HT2A/LIN-41, the proteins in which the domain
as initially described. A ﬁlamin (immunoglobulin) domain is often
ound immediately before the NHL domain [3] (Fig. 1A). Thus, the
RIM-NHL proteins consist of several distinct domains, potentially
ndowing them with functional ﬂexibility.
The RING domain is deﬁned by a regular series of cysteine (Cys -
) and histidine (His - H) residues, which coordinate two zinc ions
n a “cross-brace” fashion, where Cys in positions 1, 2, 5, 6 bind the
rst zinc ion and Cys and Hys residues in position 3, 4, 7, 8 bind
he second one (Fig. 1B; [4–6]). Conserved Cys and His residues are
ocated in the core of the domain and their binding to the zinc ions is
∗ Corresponding author. Tel.: +41 61 697 5203; fax: +41 61 697 3976.
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.0/).essential for maintaining the domain structure [4,5]. The RING
domain can act as an E3 ubiquitin ligase (Fig. 1C). On one hand,
it directly interacts with an E2 conjugating enzyme, which receives
the ubiquitin peptide from an E1 ubiquitin-activating enzyme. On
the other hand, it associates with a protein substrate, bringing it to
the proximity of E2. Notably, not all RING domains can act as E3 ubi-
quitin ligases. To possess E3 activity, a RING domain must include a
proline immediately after the Cys residue in position 7 [7] and this
residue is missing in nematode LIN-41 proteins [8]. Furthermore,
untypical TRIM proteins – Brat and Wech – lack the RING domain,
suggesting that the other domains can function independently of
the RING domain.
The B-Boxes (BBs) are also zinc-binding motives that come in two
ﬂavors (type I and type II), presenting similar, although distinct,
consensus sequences (Fig. 1B; [1,5,9]). The BBs resemble the RING,
ZZ and U-box domains of E3 and E4 ubiquitin ligases, suggesting
that the BBs may, in principle, either act as E3s per se or enhance
the E3 RING domain activity [10]. Similarly to the RING domain, BBs
also coordinate their two  zinc ions in a “cross-brace” fashion [9–11].
Although the precise function of BBs remains to be demonstrated,
they have been proposed, together with the CC domain, to provide
the binding site for a substrate ubiquitinated via the RING domain
[10].
The coiled-coil domain consists of roughly hundred amino acids,
whose amino acid sequence is not conserved. Despite that, the sec-
ondary structure is usually partitioned into two  or three coiled-coil
motives, mainly constituted by -helices that form a “rope-like”
structure, stabilized by hydrophobic interactions, often mediated
 under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Fig. 1. Functional domains of TRIM-NHL proteins. (A) Architecture of a typical TRIM-NHL protein. Composition of the TRIM (RING, BB1/2 and CC) and the immunoglobulin-NHL
(Filamin and NHL) portions of the protein. The domains are aligned from the N- (left) to the C-terminus (right) as they normally occur in TRIM-NHL proteins. (B) Consensus
zinc  ﬁnger motives present in the TRIM domain. The types of motives are in bold, key residues of the sequences are in red: RING, BB1 and BB2. “C” stands for cysteine, “H” for
histidine, “D” for aspartic acid and “X” for any amino acid. Numbers in brackets represent the range of a certain residue. (C) List of described molecular functions for speciﬁc
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y leucines [10,12]. The CC domain allows the formation of homo-
r heterodimers, promotes the formation of protein complexes
e.g., recruiting the substrate for ubiquitination) and can help to
eﬁne certain subcellular compartments [1]. The precise function
f this domain in TRIM-NHL proteins awaits clariﬁcation, but the
omain has been implicated in mRNA regulation (Fig. 1C; [13]).
The ﬁlamin domain is often associated with the NHL repeats at
he C-termini of TRIM-NHL proteins [3], potentially indicating a
hared molecular function. The ﬁlamin domain exhibits a clas-
ic immunoglobulin-like structure, constituted by seven -strands
rranged in two antiparallel -sheets [8,14], whose function, in the
ontext of TRIM-NHL proteins, has been recently linked to mRNA
egulation. Speciﬁcally, the ﬁlamin domain, together with the CC,
as proposed to recruit proteins regulating mRNA translation [13].
The NHL domain consists of ﬁve or six repeats, of roughly forty
esidues each, and folds into a barrel-like -propeller structure.
he NHL repeats have been generally regarded as structural units
nvolved in protein binding [15,16]. However, in TRIM-NHL pro-
eins, one of the two propeller surfaces is highly positively charged
nd has been proposed to directly associate with the negativelyare indicated. (For interpretation of the color information in this ﬁgure legend, the
charged RNA phosphate backbone (Fig. 1C; [17–19]). How the
speciﬁcity of RNA binding is achieved remains an important prob-
lem for the future research.
Below, we  discuss biological functions of most-studied
TRIM-NHL family members, highlighting examples where their
mutations have been linked to human diseases (Table 1).
2. Most studied family members: biological roles and
associated human diseases
2.1. Brat, Mei-P26, NCL-1 and NHL-2
Several TRIM-NHL family members have been examined in
model organisms (Fig. 2). The Drosophila melanogaster Brat is per-
haps the most studied family member. The name brat, BRAin
Tumor, comes from the larval brat phenotype [20]. In normal devel-
opment, Brat controls the decision between differentiation and
self-renewal in larval neuroblast lineages, which give rise to adult
neurons. During asymmetric division of a neuroblast Brat, together
with the transcription factor (TF) Prospero, segregates into one
54 C. Tocchini, R. Ciosk / Seminars in Cell & Developmental Biology 47–48 (2015) 52–59
Table 1
Described disease for altered TRIM-NHL protein function.
Protein Aberration type Affected domain Disease Reference
TRIM2 Point mutation (E227V) CC* Axonal neuropathy Ylikallio et al. [43]
Higher protein levels All AD Schonrock et al. [42]
TRIM3 Complete deletion All Glioma (25%) Boulay et al. [48]
Higher protein levels All Schizophrenia Martins-de-Souza et al. [53]
TRIM71 Higher protein levels All hepatocellular carcinoma Chen et al. [47]
Higher protein levels All myxoid liposarcoma De Cecco et al. [101]
TRIM32 Point mutation (P130S) BB1 BBS type 11 Chiang et al., 2006
Point  mutation (H452T) NHL Schizophrenia Farous et al., 2004
Point  mutation (D487N) NHL STM Schoser et al., 2005
Point mutation (D487N) NHL LGMD2H Frosk et al., 2002; Frosk et al. 2005
Point  mutation (R394H) NHL LGMD2H Saccone et al., 2008
Frameshift mutation (T520TfsX13) NHL LGMD2H Saccone et al., 2008
Small deletion (D588del) NHL LGMD2H Saccone et al., 2008
Frameshift mutation (I590LfsX38) NHL LGMD2H Coss et al., 2009
Non-sense mutation (R136Stop) From BB1 LGMD2H Neri et al., 2013
Complete deletion All Non-speciﬁc LGMD2H Nectoux et al. [66]
Higher protein levels All AD Yokota et al. [69]
Higher protein levels All Stress-induced affective behaviors Ruan et al. [70]
Higher protein levels All Head and neck squamous cell carcinomas Horn et al. [73]
List of human diseases that were linked to alterations of TRIM-NHL proteins – substitutio
* Protein levels are reduced. AD: Alzheimer Disease; STM: SarcoTubular Myopathy; LG
Fig. 2. Phylogenetic tree of TRIM-NHL proteins. Phylogenetic tree showing the most
studied TRIM-NHL proteins (with species indicated in brackets). Alignment of full-
length protein sequences was made with Clustal Omega (http://www.ebi.ac.uk/
Tools/msa/clustalo/). The results were sent to ClustalW2 Phylogeny (http://www.
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miRNAs, as both Mei-P26 and Brat are able to bind Argonaute-bi.ac.uk/Tools/phylogeny/clustalw2 phylogeny/) and a neighbor-joining clustering
ethod with distance correction off was used to obtain the phylogenetic tree.
aughter cell (the so-called intermediate progenitor cell) permit-
ing its differentiation, whereas the other cell, lacking Brat and
rospero, continues self-renewing [21]. Brat is an atypical TRIM-
HL protein as it lacks the RING domain. Instead, it is the NHL
omain that is critical for preventing tumor formation, as different
oint mutations in the NHL repeats phenocopy the null allele [20].
he initial insight into the biological role of Brat came from the work
n its Caenorhabditis elegans counterpart, NCL-1. While the loss of
CL-1 resulted in an increased size of nucleoli and higher levels of
RNA, these phenotypes were rescued by the ectopic expression of
rat [22,23]. Consequently, the authors speculated that the tumorns in the domains and/or altered protein expression.
MD2H: Limb Girdle Muscular Dystrophy type 2H.
phenotype in D. melanogaster was caused by an increased synthesis
of ribosomal RNA and unchecked cell growth [22]. This scenario was
supported by the subsequent observation that many genes involved
in metabolism, cell cycle, transcriptional control and ribosomal
synthesis, were overexpressed in brat mutants [24]. In addition
to its role in brain development, Brat has been shown to function
in other developmental contexts. It acts as a differentiation fac-
tor and inhibitor of cell renewal in differentiating cytoblasts (cells
derived from ovarian germline stem cells (GSCs)) [25]. Brat also reg-
ulates neuromuscular synaptic growth in neuromuscular junction
synapses [26]. In both cases, Brat has been shown to act through
the NHL repeats, repressing translation of mad, which encodes an
effector of the BMP  (Bone Morphogenetic Protein) signaling path-
way. Moreover, the NHL domain of Brat is required in early embryos
to repress translation of the hunchback mRNA. This repression also
involves the RNA binding proteins (RBPs) Nanos and Pumilio [27].
Although the RNA binding of Brat was  suggested to depend on
Pumilio [17], recent work demonstrated that Brat NHL repeats
directly associate with RNA through the electropositive surface of
the domain [18]. Very recently, the RNA binding motif of Brat has
been uncovered [28], which is a big step toward understanding the
molecular role of Brat in mRNA regulation. Finally, in addition to
the above functions of Brat mediated by the NHL domain, recent
ﬁndings suggest that the BBs also play a critical role in cell fate spec-
iﬁcation. Speciﬁcally, the BBs have been shown to be involved in the
speciﬁcation of the intermediate progenitor cells, independently
from the role in asymmetric protein segregation. Although the
exact underlying mechanism remains unclear, the BBs seem to be
indirectly responsible for the repression of the -catenin/Armadillo
activity [29].
Another well-studied D. melanogaster TRIM-NHL protein, Mei-
P26, was  initially described in the context of germline development
[30], though it also functions in the soma (for example, [31]). In
the oogenic germ cells, Mei-P26 begins to be expressed around
the 16-cell cysts stage, restricting growth and proliferation [32].
Similarly to Brat, Mei-P26 seems also to be able to control nucleo-
lar size and differentiation of the neuroblasts when overexpressed
[32]. The underlying mechanism has been suggested to involve1 (Ago1), which is a known component of the miRNA pathway
[32]. Interestingly, Mei-P26 activates miRNA-dependent silencing
of certain mRNAs, including brat, in GSCs [25,33], but inhibits the
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iRNA pathway in differentiating germline cysts [32]. In fact, these
ontext-dependent opposing roles translate into distinct biological
oles as Mei-P26 is required for stem cell maintenance in GSCs and
ifferentiation in GCs. This functional switch is suggested to involve
inding of Mei-P26 to proteins speciﬁcally induced during differen-
iation, including Bam (BAg of Marbles, a pro-differentiation factor),
gcn (Beningn Gonial Cell Neoplasm) and Sxl (SeX Lethal) [34].
nterestingly, the regulation of miRNA-dependent silencing has
een also shown for the C. elegans Mei-P26 ortholog, NHL-2, which,
imilarly to Mei-P26, binds the Ago1 orthologs, ALG-1/2, enhanc-
ng miRNA activity [35,36]. While regulation of the miRNA pathway
equires the NHL domain, Mei-P26 has been also suggested to act
s an E3 enzyme in synaptic development [37]. Nevertheless, the
nderlying missense mutation is located in the NHL domain, sug-
esting a role in RNA-mediated post-transcriptional regulation.
.2. TRIM2 and TRIM3
TRIM2 (also known as NARF; Neural Activity-related Ring Finger
rotein) and TRIM3 (or BERP; Brain Expressed Ring ﬁnger Protein)
re closely related mammalian proteins, which are predominantly
xpressed and function in the brain. TRIM2 was ﬁrst implicated in
euronal plasticity in Mus  musculus, where it interacts, via the NHL
omain, with myosin V [38]. Additionally, by acting as an UbcH5a-
ependent E3 ubiquitin ligase, TRIM2 prevents neurodegeneration
y degrading NF-L (NeuroFilament Light subunit) [39]. A further
euronal role, related to the TRIM2-mediated ubiquitination of NF-
, has been shown using cultured mouse hippocampal neurons:
hile the removal of TRIM2 causes the loss of neuronal polar-
ty and axons, the overexpression of TRIM2 induces extra axons
40]. In addition to its roles in normal development, TRIM2 has
een also implicated in tissue homeostasis. For example, TRIM2
s involved in the ubiquitination of the cell death-promoting factor
im (Bcl-2-Interacting Mediator of cell death); this function pro-
ides neuroprotection and therefore increased tolerance to mild
pisodes of ischemia [41]. Consistent with its protective neuronal
unctions, TRIM2 alterations have been linked to human diseases.
n one hand, an increase in the levels of TRIM2, possibly due
o the down-regulation of two miRNAs (miR9 and miR181c), has
een linked to the onset of neurodegenerative diseases such as AD
Alzheimer Disease; [42]). On the other hand, a childhood onset
f axonal neuropathy has been connected to mutations affecting
RIM2: a point mutation in the CC domain affecting protein sta-
ility and another mutation resulting in a precocious STOP codon
43].
Similar to TRIM2, TRIM3 was ﬁrst identiﬁed as an interactor of
yosin V in the rat brain [44], where these factors, together with
he endosome-associated proteins Hrs and Actinin-4, are present
n a complex called CART (Cytoskeleton-Associated Recycling or
ransport), which is important for the actin-dependent recycling
f plasma membrane receptors [45]. The human TRIM3 gene is
ocated in the chromosomal region 11p15, whose deletions are
ssociated with several types of cancer, suggesting a potential
umor-suppressing role of TRIM3 [44]. Along the same lines, TRIM3
evels are low in hepatocellular carcinoma tissue samples [46].
owever, TRIM3 has been mostly studied in the context of brain
umors [47]. For example, TRIM3 is deleted in around 25% of pri-
ary human gliomas [48] and low levels of TRIM3 correlate with
 higher incidence and faster development of gliomas in mice
49]. In this context, TRIM3 has been proposed to function as a
umor suppressor through the binding to and inhibition of the CDK
nhibitor p21, which promotes, rather than inhibits, proliferation
n this context [49]. Soon after, the RING domain of TRIM3, acting
s an E3 ubiquitin ligase via the interaction with the E2 enzyme
bcH5a, was shown to promote ubiquitination and degradation of
21 [16]. A role of TRIM3 as an E3 enzyme was  earlier proposedopmental Biology 47–48 (2015) 52–59 55
also in the context of the degradation of postsynaptic density pro-
teins, GKAP/SAPAP and Shank. The degradation of these factors
is important for activity-dependent synaptic remodeling. Consis-
tently, the loss of TRIM3 does not only prevent the degradation
of postsynaptic proteins but also impacts the morphology of den-
dritic spines [50]. In addition to its role in protein degradation,
TRIM3 was  suggested to post-translationally mono-ubiquitinate a
neuronal kinesin (KIF21B), modulating its velocity as a transporter
[51]. Finally, TRIM3 was identiﬁed as a presumptive p53 target in
human cells and mice and the TRIM3 protein was shown to regu-
late the intracellular trafﬁcking of GABAA receptors, probably at a
post-transcriptional level [52]. In line with the multitude of neu-
ronal functions of this protein, elevated levels of TRIM3 have been
found in the brain of schizophrenia patients [53].
2.3. TRIM32
TRIM32, initially called HT2A, is a human protein ﬁrst identiﬁed
as a mediator of the biological activity of the lentiviral Tat protein
[54]. Similarly to other TRIM-NHL proteins, TRIM32 has also been
implicated in neuronal differentiation. An initial study showed that,
in mice, TRIM32 promotes neuronal differentiation by targeting c-
Myc  for degradation and, through binding to Ago1, by increasing the
activity of the let-7 miRNA, [55]. Subsequent studies established a
connection between TRIM32 and RAR (Retinoic Acid Receptor )
(enhancing RAR transcriptional activity; [56]), the protein kinase
C  (sequestering TRIM32 in the cytoplasm; [57]), Staufen2 [58] and
p73 [59]. Apart from its roles in neurons, studies in cultured cells
and/or mice demonstrated the importance of TRIM32 for myogenic
differentiation [60] and muscle regrowth after atrophy [61].
Independently from its roles in development, TRIM32 has been
linked to at least three human diseases, where mutations affecting
distinct protein domains were identiﬁed. The Bardet-Biedl syn-
drome (BBS) is caused by mutations in the BB1 and the limb
girdle muscular dystrophy 2H (LGMD2H) by mutations in the
NHL repeats. The same mutations that cause LGMD2H also cause
sarcotubular myopathy (STM) (Table 1). BBS is a pleiotropic cil-
iopathic disorder characterized by obesity, retinitis pigmentosa,
polydactyly, hypogonadism and, in some cases, renal failure [62].
LGMD2H and STM, instead, speciﬁcally affect muscles, mostly of
hips and shoulders, though, in some cases, the disease can cause
cardiomyopathy [63]. The TRIM32 knock-out and knock-in mice
(carrying the NHL mutation D489N, corresponding to the human
D487N) have been both shown to recapitulate LGMD2H and STM
defects [64,65], suggesting that the disease may  result from a reduc-
tion in TRIM32 function rather than a speciﬁc loss of a molecular
activity of the NHL domain [64]. However, a recent study described
two patients with full deletions of TRIM32 who displayed no LGMD
symptoms [66], which suggests that molecular etiology of LGDM is
more complex than suggested by the mouse model studies.
Apart from BBS, LGMD2H and STM, TRIM32 has been studied
in the context of other ailments. In patients affected by psoria-
sis, TRIM32 has been found at high levels in epidermal lesions
caused by aberrant regulation of keratinocytes [67]. The E3 ligase
function of TRIM32 was shown to be important in the innate
immune responses against RNA and DNA viruses [68]. Moreover,
high levels of TRIM32 correlate with some neuronal disorders such
as Alzheimer [69] and chronic stress-induced affective behaviors,
where TRIM32 is supposed to act as a regulator of hyperactive
behavior, anxiety and depression disorders [70]. Furthermore,
TRIM32 has been suggested to act as a tumor suppressor [71] and
pro-apoptotic factor [72]. However, in contradiction to this idea,
elevated levels of TRIM32 occur in different models of epidermal
carcinomas [73] and in human leukemic cell lines [74].
The detrimental effects of TRIM32 aberrations observed in the
different diseases have been often explained by defects in the E3
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biquitin ligase activity. In LGMD2H, protein substrates, whose
eregulation might inﬂuence the onset and progression of the dis-
ase, include actin [75,76], tropomyosin, troponins and -actinin
75], dysbindin [77] and c-Myc [60]. Moreover, TRIM32 has been
uggested to act as a negative regulator of apoptosis, by blocking
VB-induced TNF (Tumor Necrosis Factor ) apoptotic signaling
hrough the ubiquitination and consequent degradation of Piasy (a
rotein inhibitor of activated STATs) [73,78]. Furthermore, TRIM32
as been suggested to regulate the ubiquitination and, therefore,
egradation of the tumor suppressors Abi2 (ABl-Interactor 2) [79]
nd p53 [15].
.4. Abba and NHL-1
Abba (Another B-Box Afﬁliate, also known as Thin) is a D.
elanogaster muscle-speciﬁc protein closely related to TRIM32
80]. Abba localizes to the Z-disk in muscles and is important in
aintaining the integrity of sarcomeric cytoarchitecture, both dur-
ng development and, in adults, during muscle usage [81,82]. In
bsence of Abba, different factors important for myoﬁbril stability
nd function (such as -integrin, Spectrin, Talin and Vinculin) are
is-localized [82] and Abba has been shown to genetically inter-
ct with Z-disc genes (such as -actinin, kettin/D-titin and mlp84B),
hich are important for the proper organization of myoﬁbers
81]. Although the precise molecular mechanism remains to be
etermined, Abba has been hypothesized to stabilize a protein com-
lex constituted by the above-mentioned Z-disk components, thus
nsuring muscle integrity [81]. Even less is known about the C. ele-
ans NHL-1, which, similarly to Abba, seems to be mainly expressed
n muscles [83]. Despite that, NHL-1 has been only studied in
hemosensory neurons, where NHL-1 allows cross-tissue commu-
ication in response to infections by pathogenic bacteria and to
roteotoxicity [84]. How precisely NHL-1 exerts this interesting
unction remains to be determined.
.5. Wech
Although not extensively studied, the D. melanogaster Wech
also known as Dappled) is an interesting TRIM-NHL protein. Sim-
lar to Brat, it lacks the RING domain and its expression is directly
epressed by the let-7 miRNAs [80]. As will become apparent from
he next paragraph, let-7-dependent regulation of lin-41 orthologs
s conserved. As the conservation between Wech and LIN-41 is
elatively high, the close link with let-7 raises the possibility of
 common ancestor regulated by let-7. Similar to some other
RIM-NHL proteins, the main function of Wech appears to be
n muscles, particularly in the regulation of integrin-cytoskeleton
onnection during embryonic muscle attachment [85]. Speciﬁcally,
ech has been shown to directly interact with the linker proteins
alin and ILK (Integrin-Linked-Kinase), which connect the integrin
ransmembrane receptors to the cytoskeleton. This interaction is
ependent on BBs, CC and, probably to a lower extent, NHL repeats
85].
.6. LIN-41 and TRIM71
LIN-41 (LINeage defective 41) was initially uncovered in C. ele-
ans as a member of the so-called heterochronic pathway. This
athway consists of a cascade of regulatory events, which tem-
orally control the timing of developmental transitions in certain
omatic tissues [86]. Speciﬁcally, heterochronic genes control the
roliferation versus differentiation decision in epidermal cells
alled the seam cells. Mutations in heterochronic genes either
elay or speed up seam cell differentiation [87,88]. In this con-
ext, the lin-41 mRNA was identiﬁed as a direct target of the let-7
iRNA [88,89], which inhibits lin-41 translation and promotes itslopmental Biology 47–48 (2015) 52–59
degradation via speciﬁc let-7 binding sites (LBSs) in the lin-41 3’UTR
[90]. Remarkably, the let-7-mediated repression of lin-41 is con-
served from worms  to vertebrates [91–95]. This is why the interest
in lin-41 has been for a long time let-7 miRNA-centric. However,
a number of papers have been recently published, providing new
insights into different aspects of LIN-41 biology. These include
a germline role for LIN-41 in preventing an untimely oocyte-to-
embryo transition [8], which may  involve translational repression
of key cell cycle factors [96] and a role in axon regeneration [97]. The
latter role is restricted to growing neurons, as in terminally differ-
entiated neurons lin-41 mRNA is repressed by let-7 [97]. In addition
to C. elegans, LIN-41 orthologs, called LIN-41 or TRIM71, have been
shown to play critical developmental roles in several other species.
During embryogenesis, LIN-41/TRIM71 is essential for chick and
murine limb development [93], murine neural tube closure [98],
proper timing of zebraﬁsh embryonic development [94] and main-
tenance of murine neuronal progenitors [99]. In disease, high levels
of LIN-41 have been linked to hepatocellular carcinoma [100] and
myxoid liposarcoma [101].
The murine LIN-41/TRIM71 has been reported to act in the
FGF (Fibroblast Growth Factor) signaling pathway [93,99]. In this
context, LIN-41 has been suggested to act as an E3 ubiquitin
ligase to mediate ubiquitination (presumably mono-) and stabiliza-
tion of SHCBP1 (SHC SH2-Binding Protein 1), one of the effectors
of the FGF pathway. In mammalian cells, LIN-41 is enriched in
P-bodies [102,103], which are cytoplasmic protein/RNA agglomer-
ates involved in different aspects of mRNA regulation (e.g., mRNA
turnover). Accordingly, LIN-41 has been shown to interact with
components of the RISC (RNA-induced silencing complex) in HeLa
and EC (Embryonic Carcinoma) cells and to act as an E3 enzyme
(in vitro and in vivo), interfering, in this case, with miRNA activ-
ity [103]. Speciﬁcally, the LIN-41 CC domain was  shown to recruit
and facilitate Ago2 via interaction with the E2 conjugating enzyme
UbcH5a. In this way, LIN-41 was suggested to cooperate with LIN28
in suppressing let-7 activity [103]. However, the LIN-41-dependent
ubiquitination and degradation of Ago2 have not been conﬁrmed
in another study [99]. Without much direct evidence, a hypothesis
was put forth that LIN-41 antagonizes miRNA activity through its
E3 activity, ubiquitinating and reducing the levels of Ago1/2. This,
in turn, would increase the levels of LIN28B and c-Myc, both of
which are otherwise repressed by let-7 [100]. By contrast, in a more
recent publication, LIN-41 has been shown to mediate ubiquitinat-
ion of LIN28B, allowing proper let-7 maturation and thus enhancing
let-7 mediated regulation [104]. Besides the RING domain, the
NHL domain of LIN-41/TRIM71 has also been implicated in miRNA
regulation. In ES (Embryonic Stem) cells, a miRNA-dependent inter-
action of LIN-41/TRIM71 with Dicer and different Ago proteins
was shown to enhance the miRNA pathway activity [97,102]. The
authors proposed that LIN-41/TRIM71 interacts with Ago2 through
the NHL domain mediated binding to two miRNAs, miR-302 and
miR-290. This interaction was  proposed to promote ES cell pro-
liferation by repressing translation of the Cdkn1a mRNA, which
encodes a key cell cycle regulator [102]. Clearly additional work
is needed before the complicated relation between LIN-41, its E3
ligase activity and miRNAs can be resolved.
Interestingly, the C. elegans LIN-41 has been recently shown to
lack a functional RING domain [8], suggesting a ubiquitination-
independent mode of action. Indeed, LIN-41 has been regarded
from the outset as a post-transcriptional regulator. In the C. elegans
seam cells and neurons, LIN-41 is thought to bind and repress the
lin-29 mRNA, which encodes a transcriptional effector of the let-
7/lin-41 regulatory axis [89]. In germ cells, LIN-41 must function
through a different target(s) [8] and cdc-25.3 mRNA has been pro-
posed as a candidate [96]. It has been recently shown in mammalian
cells that LIN-41/TRIM71 can be used instead of c-Myc in the canon-
ical “reprogramming” mixture additionally containing Oct4, Sox2,
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nd Klf4, to convert ﬁbroblasts into iPS (induced Pluripotent Stem)
ells [105,106]. In a previous study, a direct binding of c-Myc to the
in-41 promoter, enhancing lin-41 expression, was  demonstrated
100], suggesting LIN-41/TRIM71 as a c-Myc effector. In the con-
ext of iPS cells, LIN-41/TRIM71 has been proposed to function by
epressing the translation of the pro-differentiation TF EGR1 [105].
owever, whether this function of LIN-41/TRIM71 requires the NHL
omain remains to be tested. In the C. elegans LIN-41, a number of
esidue substitutions in the NHL domain compromise protein func-
ion [8,89,96]. A major step towards solving the molecular function
f the NHL domain has been made by Loedige and collaborators
13]. Firstly, they showed that LIN-41/TRIM71 can bind and regu-
ate speciﬁc mRNAs via their 3’UTRs and examined the relative roles
f LIN-41/TRIM71 domains in mRNA regulation. From the TRIM
omain, the CC together with the ﬁlamin domains were proposed
o recruit co-factors mediating the actual mRNA silencing, whereas
he NHL repeats alone were suggested to mediate the binding to
RNAs [13]. How the LIN-41/TRIM71 binding to mRNA affects the
ate of the transcript remains, however, unknown.
. Conclusions and remarks
From the evidence summarized here emerges a view of two
ain molecular functions of TRIM-NHL proteins: protein ubiquitin-
tion and mRNA regulation. In principle, these two  activities could
e used to the same end, i.e.,  RNA binding might bring the E3 ubi-
uitin ligase into the proximity of other RBPs, whose degradation
ould impact mRNA stability and/or translation. Effecting mRNA
ate through such a mechanism has been previously observed, in
he case of human MEX-3 RBPs [107], but whether any TRIM-NHL
rotein can function in this way remains unclear. In fact, some
RIM-NHL proteins (Brat and Wech) lack the entire RING domain
nd the nematode LIN-41 apparently contains a non-functional
ING domain. Perhaps the E3 ligase activity, shared by an ances-
ral TRIM-NHL protein, was lost from those proteins because they
volved a different mechanism of action. Alternatively, the E3 activ-
ty was “outsourced” to another protein, with which the E3-less
RIM-NHL proteins might interact. Additionally, as described for
RIM32, mutations affecting different domains can have unique
athological outcomes, suggesting that, in at least some proteins,
ifferent domains may  function independently from each other.
ntriguingly, though a few family members differ in the TRIM
omain as discussed above, the NHL domain, with its positively
harged surface interacting with RNA, is highly conserved in all
amily members [18]. This conservation suggests that the RNA
egulation may  be a unifying theme among the family members.
herefore, understanding the RNA-binding speciﬁcity of TRIM-NHL
roteins and the precise mechanisms by which these proteins affect
heir mRNA targets are the main goals for the future research.
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